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In many clinical trials and research studies on the effects of a treatment, pharmacological 
drug, or nutritional supplel~ent a placebo is used as a control. In Latin the word placebo 
means `I shall please' . Today the word placebo refers to any treatment or substance given to 
a patient or subject that is thought to be ineffective and should not produce any physiological 
benefits. ~-Iowever, an increase or improvement in the placebo grotap is often observed as 
well as the experimental group and is known as the placebo effect. This is defined as "the 
measurable, observable, or felt improvement in health not attributable to the treatment" (16). 
Evidence of the placebo effect can be seen in clinical trials such as a study by Kirsch and 
Sapirstein that studied the effectiveness of antidepressants. They found that 75% of the 
effectiveness of the drug was due to the subjects' expectations of getting better and not the 
drug itself (27). The power of a placebo and subject expectation in respect to supplements as 
well is frequently observed. For example, Ariel and Saville found a 10% increase in strength 
when their subjects, weight lifters, were told they were taking a steroid, but were actually 
taking a placebo, compared to the 2.3 %increase in strength with training alone (2). This 
large increase in percent strength gained was attributed to their belief that they shoalld get 
stronger and not to the placebo. 
The purpose of this study is to determine if there is a significant placebo effect with 
nutritional supplements a~sd performance measures of muscle strength, endurance, and 
power. ~ meta-analysis is used to quantify the size of the placebo effect and to compare a 
wide variety of supplements and different outcome measures. 
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LITERATURE ~EVIEw 
1'l~cebo Effect T~`Aieo~~es 
Different theories exist as to the cause of the placebo effect. The first and most common 
theory is the psychological or mentalistic theory. According to this theory the placebo effect 
results front the subject's expectations for the benefits of the placebo and its positive effects. 
This is reflected by the previously cited study by Kirsch and ~apirstein on the effectiveness 
of antidepressants in clinical trials where 75% of the improvement was due to the subjects 
expectations of getting better, not the effectiveness of the drug (27). 
Another theory is that the effects from a placebo are a conditioned response. This means that 
the simple act of taking a pill, getting a shot, or even seeing a medicine bottle, may trigger a 
conditioned response similar to that of a drug. There is some debate about this theory 
however, because some individuals without any past experience with drugs still experience a 
placebo effect (41). 
A third theory about the effect a placebo has on a subject is that natL~re is taking its course. 
Some speculate that when looking at the placebo effect of a drug on an injury or illness, the 
natural course of healing should be taken into account. Instead of attributing the 
improvements of an injury or disease to the placebo effect, they should be credited to nature 
running 1tS course. This is not always the case, in some instances the subjects that receive a 
placebo or experimental treatment do better than those who were ~.oi given anything (20). 
3 
A final theory as that simply receiving treatment or being part o.f a study leads to 
improvements. The placebo effect is not a result of the placebo substance, but instead a 
result of the process of receiving the placebo treatment. The attention, care, affection, and 
encouraging attitude of the experimenter or doctor may affect the mood of the subject or 
patient (9). This change in .mood is thought to cause physical changes, like releasing 
endorphins. Being part of a study has also been shown to cause improvements by increasing 
the subject's knowledge and interest in their health, which often leads to changes in risky 
behavior. An example of how simply receiving treatment can lead to improvements can be 
seen with the internal mammary ligation surgery that used to be done to decrease chest pain 
and increase blood flow to the heart. The operation consisted of small incisions in the chest 
and tying knots in two arteries of the heart. Ninety percent of the patients said the procedure 
helped, but when compared to a fake operation where only incisions were made in the chest, 
the results were the same and the procedure is no longer performed (27). 
Cli~icc~l Trials aid t~'ie I'l~ceb~ effect 
In the mid-1900s the double-blind, randomized control trial was first developed. At that time 
the placebo began to be used as a control in clinical trials, for researchers to compare their 
drugs and treatments against (23). Presently, the placebo effect is greatest in clinical trials on 
treatment of Parkinson's disease, pain, and depression. Clinical trials on drugs used to treat 
Parl~inson's disease have shown a reasonable placebo effect. The drug pergolide res~.~lted in 
improvements of Parkinson's symptoms of 17% in 4 weeks and 3 0% in 24 weeks; ho`vever, 
these were not significantly different than the 16% and 23% improvement seen with a 
placebo. A review of 36 Parkinson's studies showed that 1 ~ of the articles resulted in 
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improvements with the placebo ranging from 9-59% compared to the experimental drug. 
Even fake operations used to treat the symptoms of Parkinson's have resulted in mild to 
equal improvements in the placebo surgery compared to the actual surgery (16). 
The placebo effect in Parkinson's patients is believed to be a result of the reward theory. The 
brain releases dopamine in response to either a reward or the expectation of a reward. A PET 
scan was used to show that an injection of saline (placebo) causes a release of a considerable 
amount of dopamine in the brain which is related to an improvement in motor function. 
Since the placebo could not cause the dopamine release it must be the expectation of the 
reward, improved function, and not the reward itself, that causes the release (16). 
ether diseases or disabilities also produce the placebo effect in clinical trials. A placebo-
controlled trial on the effectiveness of secretin, tivhich was being heralded as the cure far 
autism, resulted in a 3 0% improvement in symptoms and behavior with both secretin and the 
placebo (42). This Large placebo effect could have been due to the normal variation of 
autistic symptoms from day-to-day and the high expectancy the parents had for the benef is 
of the drug. Thus any decrease in symptoms after starting the treatment would have been 
attributed to the placebo. Similar results have been seen in clinical trials of treatm~;nt for 
cerebral palsy and ADHD (42). 
7'he placebo effect can be found in analgesic research as well. Atrial where subjects 
received a placebo, belt were told it was a painkiller showed a decrease in pain due to both 
~.be opioid and non-opioid mechanisrr~s. This means that the pain was decreased because of ~~. 
physical change caused by the placebo that inhibited the pain pathway and also because of a 
psychosocial component being the expectancy of a decrease in pain. The main problem with 
placebo analgesia is that it's hard to determine if a drug effects the pain pathway and is a true 
painkiller, or if it acts on the expectancy pathway along with the placebo. Thus the only way 
to determine a drugs true effectiveness on pain is to administer it to the patient without them 
knowing. It was found that a saline injection in plain sight of the patient was just as 
successful at relieving pain as b-~ mg of morphine given to them without knowing (13). 
This is where the ethical debate of using a placebo becomes an issue. Is it ethical to give a 
subject or patient a drug without them knowing? Is it ethical to give them a placebo, but tell 
them it is a drug? in clinical trials a placebo group is used as a control to compare the 
experimental group against. If subjects are made aware which group they are in the trial 
becomes unblended and the results are no longer valid. However, using placebos is thought 
to be ethical when there is a strong scientific reason, informed consent is used, risks are 
decreased, and the trial is approved by the Institl~tional .Review hoard (37). 
1'iT~ct~~~iort~zl ►~'r~ppleme~ts~ ~~cl ~~'ie ~dacebo effect 
Clinical trials on drugs for Parkinson's disease, pain, and other disabilities are not the only 
studies where a rr~easurable placebo effect can be found. studies on nutritional supplements 
and physical performance improvements often seem to have at least a mild if not larger 
placebo effect. The use of dietary supplements to augment or improve one's health, memory, 
activity performance, strength, power, or body composition have become common place in 
today's society. dome supplements are thought to be effective by simply ingesting them, 
while others help to enhance the effects of additional activities, such as resistance or aerobic 
training. It is hard to know which supplements are actually beneficial and which are not, 
especially when "experts" and novices alike claim to have proof of the improvements caused 
by these supplements. 
Using personal testimonies as "proof' that a supplement is beneficial along with not 
_including a control or placebo group in the experimental design are two frequent errors in 
supplementation research. without baseline or control data to compare the experimental 
findings with it is hard to determine if outcome improvements are due to the supplement or a 
placebo effect. Including a placebo group along with the control group in the experimental 
design, helps to reduce the chance of a placebo effect. It can also be used to rule out whether 
the increase is due to training (the experimental and placebo group's improvements are 
similar} or to the supplement (the experimental group improved significantly more than the 
placebo). 
A classic example of how powerfiul a placebo can be is illustrated in a study by Ariel and 
Saville, which resulted in significant strength gains in trasned individuals when they were 
receiving what they believed, was an anabolic steroid, when in fact it was a placebo (2). 
Fifteen male, experienced weight lifters went through a 16-week pretreatment training 
program. Six of the 15 participated in the treatment period, ~v~~ich consisted of four 
additional weeks of training, during which time they were told they were given 10 zng of 
I~ianabol (an anabolic steroid) per day, but they were actually only receiving a placebo. 
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The authors collected data on four different lifts fora 7-week period during the prestreatment 
and the 4-week treatment period. The data showed significant strength gains in the pre-
treatment time (2.3 %increase), but a substantial gain during the treatment time (10.0% 
increase). These improvements in strength were not due to a training effect because the 
participants were already trained and were not due to a supplement because it was merely a 
placebo. Thus strength gains were attributed to their belief that they should get stronger 
since they thought they were taking a strength enhancing supplement, clearly illustrating the 
placebo effect (2). 
Chromium picolinate is a nutritional supplement that has recently gained exposure as 
possibly being beneficial in improving sport performance and body composition. A study by 
Walker et al. using both a placebo and a control group demonstrated the ineffectiveness of 
the supplement at causing significant upper and lower body strength gains in wrestlers. 
There was no significant improvements for the controls from pre to post treatment in 1RM 
for power cleans or bench press, or upper and lower body endurance (reps) or power 
measures (W•kg ~). In the placebo group there were significant improvements in strength 
with upper body endurance (reps), pre 22.29 + 1.71 and post 27.57 + 2.88, and bench press 
power (W•kg ~), pre 7.80 + 0.60 and post 9.77 + 0.92 (P< 0.05) (49). 
A study by ~ernben et al. examined the effects creatine suppls~~nentation had on muscle 
strength and anaerobic power improvements in college football players. `The resuits 
indicated that the creatine s~:~pplemented groL~p had larger in~.provements in strength (5.2%, 
3.8%, and 8.7%) and anaerobic power (19.6% and 18.E%) compared ~o both placebo and 
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control groups. However, the placebo group had small st~•ength gains (1.9% and 5.1 %) 
compared to the control group which did not show any improvement. Neither the placebo 
nor control group improved in anaerobic power. Thus, a small placebo effect may be seen in 
the measures of muscle strength, but not power (4). 
Clark et al. examined the effect of carbohydrate feedings on performance in a 40-km tune 
trial. .~11 subjects completed one time trial consuming water as a control trial. In the second 
trial subjects were given either carbohydrate or placebo, and either told they were getting 
carbohydrate, placebo, or not told at all. The percent change in power from the control time 
trial for subjects told they were getting carbohydrate was 4.3 ± 4.8 %, the majority of that 
improvement was seen with the placebo group, told placebo 0.5 ~ 5.8%, and not told - l . l ± 
8.5 %. Subjects who were told they were receiving carbohydrate but it was really placebo 
had a positive change in power of about 7%, but subjects who were receiving the 
carbohydrate but were told it was placebo had no change in power. So, when the subjects 
believed they were taking a supplement that was supposed to be very beneficial for strength 
gains and body composition, they saw improvements even when taking a placebo, yet when 
they were told it was a placebo l~nost subjects saw no performance improvements, even those 
taking the carbohydrate (12). 
The main purpose of this meta-analysis was to determine whether there is a significant 
placebo effect found in studies on nutritional supplementation and increases in the 
perfor~rnance outco~n.es of muscle strength, endurance, and power. If the research hypothesis 
is t~2~e and a placebo of°feet does exist, there will be a signxtioa.nt difference between ~h~ 
placebo group and the control group. This study will focus on the effect of supplementation 
on gains in strength, endurance, and power rather than muscle substrate levels and other 
physiological markers due to the fact that a placebo effect or psychological influence will not 
impact any inherent changes seen in substrate levels. Additional hypotheses include the 
effect certain variables have on the presence of a placebo effect. The first is that studies that 
are double blind will have a smaller chance of displaying a placebo effect. The second is 
that trained subjects may be more likely to display a placebo effect than untrained subjects, 
owing largely to the fact that trained individuals are more likely to have preconceived ideas 




The initial Iiterature search was performed using the PubMed and PsyclNFo databases, with 
keywords; (nutritional) supplementation, placebo, training (or resistance/strength training), 
and muscle power, strength, and endurance. The online database for the Jo~u-nal of Applied 
Physiology was also searched using the same keywords. All of the matching titles were then 
screened and those that did not include a dietary supplement, a placebo group, or used 
subjects that were not considered healthy were not considered. 
From there, inclusion in the meta-analysis was based on the following criteria. Studies had 
to have been published in a peer reviewed journal. The duration of the treatment time was 
not a factor; however, it needed to be long enough for improvements to develop. As far as 
the supplements used, the dose given had to be higher than the normal daily amount. The 
studies were not restricted by the method or how often they were given or even to those that 
used only one supplement. The studies included had to have measured changes in strength, 
muscle endurance, or muscle power. 
data Coding 
All of the studies that were to be included in the meta-analysis were then placed on a coding 
sheet. The following information was placed on the code sheet for each study: age, gender of 
subjects, same or different groups, random, familiarization session, double blind, study 
length, outco~i~e meas~.~re, training load, training frequency, and training stat~.~s. These 
characteristics were chosen because of their possible impact on the placebo effect. 
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Effect Size Calculation 
An effect size was calculated for each study so that the results could be put in a similar unit 
and compared. The effect size (ES), pooled standard deviation (Sp), standard error (SE), and 
inverse variance (w) of changes in muscle strength, endurance, and power were calculated 
using the following formulas from Lipsey and Wilson (31): 
Within groups formulas were used for post-pre supplementation calculations: 
ES = ~XT? — XTl 
sp 





2 2 2 l
S p — ~s Tl+s  T21 
2 
Having XT2 =post, XTr = pre, S 1 =standard deviation pre, S2 =standard deviation post, ~ r = 
0.6 
between groups formulas were used for post-post supplementation calculations: 
(4N-9) 
Sp = ~ ~n~-1) SG~ 2 + (n,-1) SG22
(nl-1) + (n2-1) 
vv = 1 
SE2
ESsm = X~  — X?
Sp
SE _ ~ nl  + n2 + (ES)
2
(nl)~n2) 2~nt+n2) 
-laving ES~m = u:nbiased effect size, X 1 =group 1, X2 =group 2, SG 1 =Standard deviation 
group 1, ~ SG2 =- standard deviation group 2 
Effect sizes were calculated :for the difference between post and pre supplement for each 
groL~p included in -the study; treatment, placebo, and control (if included). Effect sizes were 
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also calculated between groups (treatment-placebo, placebo-control, and treatment-control) 
to determine the difference in post supplementation measures. An ES of 0.0 would indicate 
that there was no difference between the values being compared; an ES of 0.2 was considered 
small, 0.5 was average or moderate, and 0.8 a large ES. 
Statistical flnalysas 
The effect sizes for between groups comparisons and within groups comparisons were 
determined according to appropriate formulas in Lipsey and Wilson (31) and Thomas (46), 
and were analyzed using the SPSS statistical package. The original ES data were examined 
using exploratory statistical methods to determine whether their distribution was 
approximately normal. A backward elimination multiple regression was used to determine 
which independent variables were significant predictors of the effect size. To adjust for the 
lack of normality in the distribution of the original effect size results, additional backward 
elimination multiple regression analyses were conducted on the ranks of the effect size data 




Uf the 64~ studies that were found pertaining to nutritional supplements only 3 7 met all 
criteria and were included in the meta-analysis. The characteristics of each of the included 
studies are summarized in Table 1. 
Post-treatment Group Co~aaparisons 
When analyzing the difference of the mean effect sizes calculated for the post-treatment 
groups, there was a significant difference between the treatment group and the control group 
(ES=0.98). Comparison between the placebo group and control group resulted in a large 
effect size (ES=0.67), indicating a difference between the two groups, but not as large as 
compared to treatment. The mean effect size between the treatment and placebo groups (ES= 
0.06) demonstrated the mean post-treatment results were not significantly different for the 
two groups (Figure 1). 




~o~a~t~~~~~-P~I~ac~~ ~~,~~c~lxr~;{~~ti~1 ~'a~~o~t~~~~t a~~s~~~9 
Figure 1. Mean e#feet sues calculated for post-post supplementation for between the control, placebo, Zrid 
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Table 2. Mean effect size, standard deviation, and 95% confidence intervals for each ceded 
variable. 
Variable I~ I~Iean ES SD 95~'/o CI 
Post-Post 
Treatment-Placebo 123 0.0574 0.576 0.103 
Treatment-Control 11 0.9763 * 1.706 1.146 
Placebo-Control 9 0.6721 0.992 0.763 
Outcome 
Strength 193 0.7425 * 1.180 0.168 
Endurance 40 0.3169 0.459 0.147 
Power 101 0.1498 0.550 0.109 
Training Load 
None 39 0.1862 0.200 0.065 
Moderate 57 0.6277* 1.257 0.333 
Heavy 23 8 0.53 81 0.998 0.127 
Training Frequency 
None 39 0.1862 0.200 0.065 
1-2 hr/wk 24 0.4081 0.723 0.305 
3 -4 hr/wk 169 0.7115 * 1.104 0.16 8 
5-7 hr/wk 102 0.3315 0.987 0.194 
Familiarization 
No 198 0.4035 1.001 0.140 
Yes, not good 44 0.3093 0.717 0.218 
Yes, good 92 0.8436* 1.033 0.214 
Training Status 
Untrained 192 0.6969 1.046 0.149 
Trained 142 0.2627 0.870 0.144 
Double Blind 
No 37 -0.058 0.707 0.236 
Yes 297 0.5833 1.006 0.115 
Study Length 
< 1 week 18 0.1203 0.7$3 0.389 
> 1 week 316 0.5 3 46 1.004 0.1 I 1 
Randomization 
Yes 330 0.5189 1.001 0.108 










247 0.4956 1.067 0.134 
33 0.3471 0.757 0.268 
54 0.6907 0.753 0.206 
221 0.5696 1.078 0.143 
39 0.3236 0.881 0.286 
74 0.4406 0.772 0.179 
Same 3 6 0.3 3 86 1.416 0.479 
Different 298 0.5333 0.935 0.107 
`The mean d~.fference is significant at the .OS level. 
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I~zflasence of (~tlie~ E'~c,~e~in~ental ~eslgn F`acto~s 
Certain factors of a study have a significant impact on the mean post-pre effect size. There 
was a larger effect size (decreased risk of a placebo effect) for studies that were double blind, 
than for those that were not. Studies that included awell-done familiarization trial had a 
significantly larger effect size than those that included a familiarization trial that was not well 
done or did not include familiarization at all. There also tended to be a larger effect size for 
the studies that used strength as the outcome measure, compared to endurance or power. A 
moderate training program, including a moderate resistance load and 3 -4 hr/wk of training, 
resulted in the largest rnean effect size (Table 2). 
Table 3. Analysis of variance of backward elimination multiple regression 
Source Type III Sum 
of Squares 























12 88162.347 113.45 .342 <.001 
1 668152.402 71.65 
5 115459.770 61.91 
1 27994.781 3.00 
2 25296.063 5.43 
1 119042.017 12.77 











Sign scant Determinants o, f Effect Size 
The results of the elimination regression are found in Table 3. This analysis indicated which 
variables were significant determinants of the effect size. Significant variables included: 
group (control, placebo, or experimental), whether or not the study was double-blind, 
frequency of training, good/poor familiarization trial, and if the groups were the same or 
different. The following variables were not significant determinants: age, gender, study 
randomization, length of study, outcome measure, training load, and training status of 
su ~ ects. 
Control, Placebo, and Experimental Group Differences 
The results of a univariate ANOVA of ranked effect sizes indicated there were no statistically 
significant differences between the mean overall effect sizes of the control, placebo, and 
experimental groups. The mean effect size was calcelated for the change from pre to post-
supplementation for each group. All three of the group's effect sizes were considered 
between moderate and large, indicating a significant difference between pre and post 
measures. The mean effect size of the placebo and treatment groups tended to be larger than 
the control group, but the difference was not statistically significant. 
Determinilzg Non~no~•~nal Distribution 
A Quantile-Quantile (Q-Q) plot was used to determine if the t~vo data sets, expected effect 
size values and actual effect size values, have a common distribution. In this analysis, -the 
actual effect size values were plotted against the expected values which have a normal 
distribution. Thus, if the original effect size data ~avere normally distributed tl~e data points 
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would fall generally along the 45-degree reference line. The original data do not fall along 
this line because they are not normally distributed (Figure 2). In addition the original effect 
sizes also had a skewness of 1.94 + 0.14 and kurtosis of 7.20 + 0.27. Thus ranked effect 
sizes were used in place of the original effect sizes for all additional analysis. 























Figure 2. ®riginal effect size values plotted against the expected normal values; if both data sets have similar 
distributions the data points should fall along the 45-degree reference line. 
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I~IS~USSI~N 
The major finding of the meta-analysis was that the mean effect sizes calculated for the 
difference between post-supplement measures of the three groups suggests a placebo effect. 
The effect sizes are: 0.06 for experimental-placebo, 0.98 experimental-control, and 0.67 
placebo-control. Since the effect size comparing the experimental and placebo groups is 
positive the change in the experimental group was larger. However, this is a small effect 
size, implying the difference between the two groups was not meaningful. Thus, the 
experimental and placebo groups experienced an equivalent increase in the outcome measure. 
In comparison, the effect sizes calculated for the differences between the placebo and control 
groups (0.67) and experimental and control groups (0.98) clearly shows a considerable 
difference between the groups. As could be expected if nutritional supplements were 
beneficial, the post-supplement measurements of the treatment group would be significantly 
larger than those of the control group, this is confirmed with the large effect size. The ratio 
of the post-supplement effect size between placebo and control groups with the effect size 
between the experimental and control groups suggests the placebo effect accounts for 
roughly 70% of the total effect. ~o any improvements seen with supplementation sho~rld not 
be solely attributed to the supplement itself. 
Analysis of~ the past-pre supplementation data for all groups showed that certain variables 
may impact the effect size. One such variable was whether a familiarization trial was 
~n~;luded in the study and if~ there was one, how yvell was it described and implemented in tl~e 
study. The data show that if there was a well done familiarization trial in the study, there is a 
22 
significantly larger effect size. The study by Kilduff et al. included a detailed description Of 
the familiarization process, which included two separate trials that were used to assign 
subjects to each group. The mean effect size for this study was 0.4 (25). The analysis also 
indicates that including a poor familiarization trial in a study is the sarn.e as not including one 
at all. Two studies included in this meta-analysis both had mean effect sizes of -0.05; ®ne by 
Clark et al. had a poor familiarization trial, ̀ vhile the one by Crist et al. had none at all (12, 
15). Thus, when a subject was familiar with the protocol of the study before any data was 
collected and knew what to expect there was a greater difference between the pre and post 
supplement rneasurenr~ents. 
1~nother study characteristic that influenced the amount of change from pre to post is whether 
the study was double blind. The analysis shows that a study that is double blind has an effect 
size that tends to be higher than if the study was not blinded, however, the difference is not 
statistically significant. This makes sense in relationship to the placebo effect. A, study by 
Clark et al. examined the effectiveness of carbohydrate supplementation and time to 
completion of a cycling time trial. The study was not double blind, in fact, subjects were 
further divided into subgroups based on what they were told they were being given; some 
were told they were receiving carbohydrate, some placebo, and some were not told either. 
The mean effect s ~lze calculated for the difference between the treatment group and placebo 
group in post-supplement measures in this study was -0.75 (12), indicating that the two 
~~roups were not significantly different after supplementation. 
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In comparison, a study on the effect of creative supplementation and improved strength by 
Burke et al. resulted in a n7.ean effect size of 0.63 for the difference between treatment and 
placebo groups on post-supplement strength increase (10). This study was completely 
double-blind, all supplements were prepared and coded by someone outside of the study and 
which group the subjects were in was not exposed until the end of the study. Thus, when the 
study was double blind and the subjects were unaware if they were receiving the supplement 
there was a larger difference in the groups; the treatment group improved more compared to 
the placebo group. However, when the study was not double blind the treatment and placebo 
groups were not different from each other and a negative effect size indicates the placebo 
group was actually greater than the treatment group, both indicating a probable placebo 
effect. It is important to note that only 5 of the studies included in the meta-analysis were not 
double blind. Thus, even though the majority of nutritional supplement studies are double 
blinded, those that are not may have a greater chance of displaying a placebo effect. 
The type of outcome measure used to establish the effectiveness of the nutritional 
supplement may also be important in determining the effect size and the presence of a 
placebo effect. A1.lalysis showed that when the measured outcome was improvement in 
strength the rnea.n effect size was 0.~4, for endurance it was 0.32, and for power it was 0.15. 
This indicates that the chances of a study having a placebo effect tend to be greatest when 
muscle power is the outcome measurement. However, -the limited number of studies 
included in the meta-analysis that measured muscle power (n-11) and endurance (n=10) 
compared to muscle strength (n=25) must be considered ~,rhen evaluating the results. Thus, 
since the effect sizes for power and endurance were considered small and the ellrnination 
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regression showed that outcome measure tivas not a significant variable in determining effect 
size, it can be implied that the specific outcome measure does not significantly contribute to a 
possible placebo effect. 
Ililost of the studies included involved some type of training regimen that varied in resistance 
load and frequency of training. Analysis of the .mean effect sizes for the different levels of 
these two variables showed that the studies which included a moderate resistance load and 
trained 3 -4 hours per week had the greater effect sizes, 0.63 and 0.71 respectively. 
Therefore, using a moderate training protocol in respect to load and frequency is shown to be 
the most successful in displaying the effectiveness of the nutritional supplement. ®nly two 
of the eight studies that examined the acute effect of nutritional supplementation showed a 
positive result from the supplement (28, 29}. 
+ether variables that were thought to possibly contribute to the magnitude of the effect size 
but were found to not have a significant influence included subject age, gender, and different 
groups/cross-over study. Each of the different subgroups of these 3 variables had similar 
effect sizes so it can be Inferred that they have no influence on effect size. There are two 
variables that did not show a significant influence on the effect size, study length and subject 
training status. Analysis indicated that a study Lasting longer than 1 week had a larger effect 
size, 0.53 compared to 0.12, so there was a greater difference between groups and more of a 
chance to observe possible i~~provernents due to the supplement, ~..esL~lts also revealed that 
entrained subjects tended to have a larger e f~fect size and thus show a superior enhancement 
with supplementation, 0.70 versus 0.26 for trained. This supports the hypothesis that trained 
25 
individuals may demonstrate an increased chance of a placebo effect, possibly due to their 
increased exposure and background kno`vledge of nutritional supplements and what benefits 
they are purported to offer. 
Effect sizes calculated for the pre- to post- difference between experimental, placebo, and 
control indicated there was not a significant difference between any of the three groups. The 
effect sizes calculated for each of these groups fell between moderate and large, 0.73, 0.73, 
and 0.67. This finding suggests there was a large difference between pre and post 
measurements in each group. The experimental and placebo effect sizes tend to be slightly 
larger than the control group, but similar to each other. It could be speculated that even 
though some Improvement results from using a nutritional supplement, the benefit is similar 
to that of a placebo treatment. Thus, when the effect sizes of all the studies included in this 
meta-analysis were analyzed together the results shoved there is a considerable placebo 
effect when examining nutritional supplements and their effect on muscle strength, power, 
and endu~•ance. 
The intent of this meta-analysis, however, is not to contradict the effectiveness of some 
nutritional supplements. As the research indicates, some supplements have been shown to be 
beneficial. The results of a study by Bemben et al. indicated that muscle strength increased 
by as much as $.7% with creative supplementation, while the placebo group increased by 
5.1 %and the control group had no change (4). Creative supplementation also increased 
anaerobic ~ow~er "~y 19.6%9 but there vas no improve, ~~ent sce.~ ~~ either placebo or contra i 
grou~~s (~). HIVIB has also been shown to improve muscle strength as r~neasured by change in 
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bench press. The placebo group increased by 5.2, while the group supplemented with HIi~IB 
improved 7.5, which was significantly different from the placebo group (39). 
Even though many of the studies included in this meta-analysis found improvements with 
supplementation, there were enough that did not, such as one study that examined the effect 
of adding HMB to a resistance training program. This study by Gallagher et al. resulted in a 
similar increase in strength (1-fZM for 101ifts) for the control group and groups with two 
different levels of HMB supplementation (19). Thus, even tho-ugh some of the studies 
individually illustrated the benefits of some nutritional supplements, when all of the studies 
were analyzed together the studies that may have shown no improvement or an increase in 
the placebo group obscured any increases that may have otherwise been observed. 
~ possible limitation of the study is the number of studies that contained a control group. 
Very few of the studies that met the inclusion criteria contained an experimental, placebo, 
and control group. Most of the studies included either a placebo group or a control group. 
There were only 5 studies that included all three groups and only 11 effect sizes comparing 
treatment-control and 9 effect sizes comparing placebo-control. This is compared to the 123 
effect sizes calculated for treatment-placebo differences. Thus, when analyzing the data with 
such a small number it is possible for one outlier to have a large effect on the results. 
Additional reseaY•ch on the presence of a placebo effect is also needed in respect to other 




In conclusion, the results of the meta-analysis indicate the presence of a placebo effect in 
studies on nutritional supplementation and improvements in muscle strength, endurance, and 
power. 'This is obvious when examining the mean effect size between treatment, placebo, 
and control groups for post-supplementation measL~res. If a significant placebo effect does 
exist, we hypothesized there would be very little difference between the treatment and 
placebo group, while both group outcomes would exceed those in a control group. The 
observed effect sizes for the treatment-placebo (ES = 0.06), placebo-control (ES = 0.~7), and 
treatment-control (ES = 0.9~) support this hypothesis and indicates the placebo effect 
accounts for roughly 70% of the total effect of supplementation. 
Thus, it is indicated that when setting up a research study on the effect nutritional 
supplementation has on Improvements in strength, power, and endurance certain criteria must 
be met. These include using both a control and placebo group, a good familiarization trial, 
making sure the study is double blind, using a moderate training load and frequency. In 
respect to nutritional supplements it seems that using untrained individuals and measuring 
improvement in strength performance are also more effective. 
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A~PEl~tDIx: ADDI`7C'IOI'~tAL LI~'E~A~'iJRE ~.EVIEw 
~lc~cebo Effect 
However, there are also negatives to using a placebo group. Some studies inform their 
subjects that they ~~nay be receiving a placebo, while others do not. In either case, subjects 
may report or show improvements in strength or other measures because neither the subjects 
nor the experimenters know who is in which group. Since there is the possibility that they 
are receiving an advantageous supplement they think they should be improving and it is often 
this belief in the benefits of the treatment alone that causes the desired physical 
improvements. This is known as the placebo effect, which is an improvement or increase in 
a measurable outcome attributed to an ineffective treatment. The recipient of the treatment is 
unaware that they are receiving a "fake" supplement and because they expect to experience 
improvements or changes they often do. 
~'lacebo ~& E.~per~i~nent~rl Groups ~xt~i Specified T~ain~ng 
Many studies show the benefits of adding a supplement to a resistance training program. 
One such study showed the effect creatine had when combined with another supplement and 
resistance training. Twenty five division I football players received 15.75 g/d of HPCE pure 
creatine added to Phosphagen HP for 28 days and participated in 5 ho~irs/wk of resistance 
training and 3 hours/wk of agility/speed training. This resulted in a significant increase in 
total body weight in the creatine (Cr} group (2.42 +/- 1.41{g) compared to the placebo (P) 
group (0.85 +/- 2.2 kg) (30). The creatine group also showed an increase in the volu~~ne of 
weight lifted during the bench press that was significantly higher ~-han the placebo group (Cr: 
225 +/- 246 and P: -5 +/- 134) as well as a larger change in the total volume lifted with all 
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three lifts combined (P: 1,105 +/- 429 and Cr: 1,558 +/- 645). Cycle ergometer sprint 
performance was also affected, the creatine supplemented group showed a significantly 
higher amount of work done in the first 5 sprints compared to the placebo group. These 
results support the thought that strength and power activities are improved with the 
supplementation of creatine for 9-56 days (3Q). 
ether creatine studies have found similar improvements in maximum strength, muscle fiber 
area, maximum arm flexion torque, and functional task performance with considerably 
smaller doses (5 g), less intense training, and in women and older individuals (7, 47). A study 
by Ayoama et al. examined the effects of creatine supplementation in women (collegiate 
softball players) and if previous anaerobic exercise would increase the effect (3). The results 
indicated that in trained women, the supplementation of creatine along with previous 
performance of anaerobic activity leads to an increase in mean strength and muscular 
endurance with repeated contractions. This was shown by the increase in mean torque for -the 
final 20 contractions in the last three measurement groups compared with the initial 
measurement for the #2 creatine group which participated in anaerobic exercise and received 
both an initial dose of 20 g/d Cr and 3 g/d Cr for the last 2 weeks (3 ). 
The effects of other supplements such as R-hyd~•oxy-~3-methylbutyrate (H1VIB) have also been 
shown to improve strength, fat~free mass, and decrease muscle proteolysis. A study by 
I'~i.ssen et al. consisted of two experiments; one used a placebo (P) and two different levels of 
~I~~I.I3 and also examined the influence of normal protei~l intake and higher protein 
s~ ~pplementation. The other used a placebo and only one H1VIB group and used a more 
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intense resistance training program. The first study showed that total strength increased over 
3 weeks in all three groups, but was significantly higher in the two HMB groups (P: 8% 
increase, 1.5 HMB: 13%, and 3.0 HMB: 18.4%, P~0.02} (36). Also, the amount of essential 
amino acids in the plasma is an indicator of the amount of muscle break-down, and was 32% 
higher in the placebo group, 9% lower in the 1.5g, and 18% lower in the 3.Og (36). 
The second study showed that fat-free mass was initially significantly impacted by HMB 
supplementation, as was strength, shown by the significantly higher change in bench press in 
the HMB group (15.0) compared to the placebo group (5.4) (36). Similar results for 
increases in upper body strength (P 5.2 +/- 0.6 kg HMB 7.5 +/- 0.6 kg P=0.008) and 
decreases in muscle break-down have been displayed in women and in both trained and 
untrained participants (39). 
Since many supplements have been shown to help improve strength and performance it is 
thought that taking more than o.ne supplement may be even more beneficial. This nay be the 
case with creatine and HMB. The study by Jowko illustrated that lean body mass and 
strength did increase when subjects were given each supplement individually, but the 
increase is significantly higher when subjects receive both creatine and HMB. Lean body 
mass improved 0.92 kg with creatine, 0.39 kg with HMB, and 1.54 kg with Cr/HMB over• the 
placebo, which was statistically significant (p=0.05). Strength also increased at a similar rate 
compared to the placebo, 3 9.1 kg with creatine, 3 7.5 kg with HMB, and 51.9 kg ~vit.~~ 
Cr/HMB (p-0.001). "This s~~ppoi•ts the notion that Gr and ~-~ii/1:~3 are additive 1n the~.r 
physiologi~;al effects and thus result in greater improvements (22}. 
3b 
Even when supplegnentation does not result in strength increases, it may improve other power 
outcomes. Supplementation of ~3.0 g/day of HMB was found to cause a significant 
improvement in peak isometric torque (p<0.05) and ~6 g/day of HMB increased peak 
isokinetic torque when combined with 3 days/wk for 8 weeks of resistance training on 10 
exercises at 80% 1RM (p<0.05). However, no statistically significant difference in strength 
improvement was found between the placebo and the two levels of HMB (19). 
Supplementation of essential amino acids has also been found to improve aerobic endurance 
without changes in strength. By using treadmill time to exhaustion the EAA supplemented 
group went from 13.15 +/- 3.67 min pre-treatment to 14.73 +/- 4.26 min post-treatment 
(p<0.05), while the placebo group did not improve significantly (1). 
In contrast, other studies show no improvement in strength, body composition, or other 
measured outcomes with the addition of a supplement. Even though many studies show 
statistically significant changes associated with creative supplementation, this is not always 
the case. In two studies using 5 g of creatine supplementation in older and college-aged men 
using moderate resistance training and interval sprint training neither body composition 
measurements nor power output measurements were significantly changed (p>0.05) (14, 17). 
Yarasheski et al. showed that supplementation of growth hormone had no added benefit for 
younger or older men. After 12 weeks of resistance training and supplementation in young 
men a similar strength increase was seen in both the ~0 µg GH s~~pplemented group (54 -~-/- 
5%) and the placebo group (50 +/- 5%) ;both were significantly (p<0.01) different from pre-
training (51). data collected on strength increases with GH supplementation in older men 
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supported the previous data, the supplemented group increased S 7 +/- 7% and the placebo 
group increased 60 +/- 8% (51). Thus, even though strength gains were made with GH 
supplementation, they were not significantly higher than the placebo group. This indicated 
the GH supplementation is of no added benefit for increasing strength. 
According to a study by Slater et al. HMB supplementation in well-trained athletes did not 
result in significant strength gains. The supplementation group did show improved strength, 
however, it was not significantly different from the placebo group. Thus the strength gains 
were due to the training and not the supplement (43). 
A sttidy on the effects of supplementation with chromium picolinate (CP) on body 
composition found that the CP supplemented group had a larger decrease in body fat 
compared to the placebo group; however the difference was not statistically significant. 
When the two groups were combined together the difference between pre and post-treatment 
body fat was significant at p<0.05, however, the authors attributed this to the resistance 
training like in the previous study by Slater et aL (49). 
Supplementation of testosterone precursors has also proved fruitless. Even though taking 
DHEA, androstenediol, or androstenedione increases serum androstenedione Levels, they do 
~~ot affect the serum testosterone levels and so do not lead to strength increases (6, ~). The 
study by Brown et al. examined both the short and long-term effects of D~--IEA, but found that 
with both, serum a:ndrostenedione levels increase (by as much as 150% ~n ~0 rn~n~~t.e~) ~}~~t 
serum testosterone was unchanged. Changes in strength for both groups resulted in 
significant increases from pre-training levels; but the RHEA group was not significantly 
different from the placebo group (8). 
Hellsten et al. performed a study on the effects of ribose on resynthesis of adenine 
nucleotides after intermittent exercise and if the exercise performance was affected by the 
decrease in muscle ATP levels. The results indicated that supplementation of ribose did 
increase the rate of recovery ofpre-exercise levels of ATP compared to the placebo group 
(p<o.05). However, even with the faster recovery of ATP with ribose supplementation there 
was not a significant improvement in performance. both mean and peak power output were 
statistically similar for the two groups (p>0.05) and the total work performed both between 
groups and between time was not different (21). Thus even though ATP recovery ~Tas 
increased, there was no added benefit of ribose supplementation to any measurable 
performance outcome. 
Placebo & ~xpe~i~te~tal Groidps avith U~super~vised ~'~aitzi~ag 
Mot all nutritional supplement studies use a specific training regimen. dome studies allow 
the subs ects to continue their normal training program or j ust require them to keep an 
exercise log. I~ilany of these studies have individuals that are all trained in the same thing so 
that even though they are not all following the same protocol, the type and amount of training 
is similar. The use of unsupervised training in supplementation studies has resulted in both 
supporting and refuting the benefits of supplements. 
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One such study examined the effects ofandrogenic-anabolic steroids also shows the power of 
a placebo effect. Dine adults were each supplemented with a placebo, 100 mg of testosterone 
cypionate, and 100 mg of nandrolone decanoate for 3 weeks each and participated in 
resistance training (15). They were objectively tested after each of the 3 treatments and were 
then asked to subjectively rate, 1 to 10, each of the treatments as far as how much total 
strength they thought they gained. The results indicated that there were no significant 
differences in strength or power between the 3 treatments, but the subjective ratings show 
that the subjects felt they had more strength gains with testosterone (7. ~ +/- 0. ~ 7), than 
nandrolone (6.0 +/- 0. ~ 1), and finally placebo (4.3 +/- 0.66). Even though the objective 
measurements did not show any increases in strength or power, the participants thought they 
felt stronger after taking all 3 treatments, especially testosterone (15). This increased feeling 
of strength could be partly responsible for why steroids have been so widely used and 
thought to improve strength. 
Another study that used national wrestlers in their off-season as the subjects and creatine 
supplementation resulted in similar findings of a significant improvement in anaerobic 
activity. A statistically significant difference between average power, peak power, and body 
weight (p<0.01) was found between the creatine and placebo groups (28). 
Two studies looking at the effects of caffeine and glucose plus branched-chain amino acids 
on cycling performance (muscle power) used trained cyclists as subjects and allo~,ved them to 
continue their norn~a.al traini~ og protocol. The study by ~~ovacs et al. showed that cycling time 
trial performance improved with the addition of caffeine to acarbohydrate-electrolyte drink. 
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As the amount of caffeine increased, the amount of tune to finish the set workload decreased; 
62.5 ± 1.3, ~ 1.5 ± 1.1, 60.4 ± 1.0, 5 8.9 ± 1.0, and 5 8.9 ± 1.2 minutes (29). In contrast, the 
study by Madsen et al. on the effect of glucose and glucose plus branched-chain amino acids 
on 100 km cycle performance showed that neither supplement had any effect on the 
performance outcome. Time to complete 100 kn1 was 160.1 ± 4.1 min for the glucose 
supplement, 157.2 ± 4.5 min for the glucose plus branched-chain amino acids, and 159.8 ± 
3.7 min for the placebo group (32). 
Three studies on tie effects of supplementation on endurance performance without a standard 
training program all showed no improvement in the experimental group over the placebo. 
One study examined the effect of pyruvate supplementation for 1 week in trained cyclists. 
The data indicated that the time until exhaustion did not significantly improve in the pyruvate 
group (88 ± 8 min) compared to the placebo (91 + 9 min) (34). 
The second study evaluated the effects of fish oil and vitamin E supplementation on cycling 
endurance. Unlike previous studies, this study did not result in any improvement with the 
supplementation. Endurance test times changed from the baseline measure by 0.11 ± 0.49 
ruin with placebo, -0.23 ± 1.3 S min with fish oil, and -0.07 ± 1.1 ~ min with fish oil and 
vitamin E (38). 
The use of herbal supplements is often thought to be beneficial. however, a study on the 
effects of Cordyceps ~inensis (CordyMax Cs-4) supplementation on aerobic capacity and 
endurance performance did not support this hypothesis. The 22 .male trained cyclists 
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completed apre-time trial and V02 peak test, had 5 weeks of either CordyMa~ Cs-4 or 
placebo supplementation, then performed apost-V(~2 peak and post-time trial. The results 
indicated there was not a significant improvement seen in either the Vol peak or tirr~e trial 
performance with supplementation (40). 
~'1 acebo ~& Experi~tten tal Gro cps with n o ~'~arn ing 
Some nutritional supplements claim to be effective in improving outcome measures even 
without training of any kind. These supplements are supposed to have an acute physiological 
effect which leads to physical improvements in strength, power, endurance, or other 
measures of performance. 
In a study by McKenna et al. on the effects of creatine a placebo effect was displayed. The 
subjects were informed that they would be in either the creatine supplemented or placebo 
group, that creatine has been shown to improve performance, and that how long those 
improvements last is unknown. The results showed similar statistically significant increases 
in maximal intermittent cycling, peak power, and work output for both creatine and placebo 
groups. The experimenters concluded that a placebo effect had taken place due to the 
infol-mation the subjects were given before the study, causing them to believe that ~~heir 
performance would increase with supplementation (33). 
Similar results were found with a study on the effects of Vitamin D supplementation and 
physic~~.l performance in the older population. IJven though ~~ere vas a significant increase 
in 25-hydroxyvitanlin D (~SC~HD} in the cholecalciferol supplemented group co~npa~•ed to 
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the placebo group (p<0.001), there was not a significant improvement in strength, 
performance, or perception of health in the participants (24). Hence, even though 
supplementation of some products may cause physiological or physiological changes, 
measurable outcomes are not always significantly improved. 
when the results for the experimental and placebo groups show there is not a significant 
difference in the measured outcome it can easily be assumed that the supplement is of no 
additional benefit. However, when the placebo group shows significantly greater increases 
than the supplemented group, explanations are rather limited. ®ne such explanation could be 
that the groups were not chosen at random and would not have similar results. Another more 
likely reason is the placebo effect. Since the subjects did not know which group they were 
in, but knew they could be receiving a supplement that had the potential to increase whatever 
outcomes were being measured, they may have been displaying improvements only because 
they thought that they should. 
Campbell et al. studied supplementation of 17.8 ~.~mol of chromium picolinate and resistance 
training for 12 weeks. The results indicated that there were no changes in body composition 
or muscle fiber area in the supplemented or placebo group and that muscle strength at 20, 40, 
60, & 80% of 1 RI~1 improved in a similar fashion for both groups (p<0.0001). Except for 
knee extensions, where the placebo group increased strength significantly more than the 
supple:n~ented group at 20% (p=0.005), 40% (p=0.024}, ~ 60% (p=0.069) (11). 
Physiologically there is no explanation for why the placebo group ~~ould improve that much 
compared to the experimental group, thus their belief that they should be getting stronger 
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Ynay have influenced how they felt and how much they lifted. Thus, many studies that 
include a placebo group often display at least a slight placebo effect; however, it is not 
mown whether this effect is meaningful. 
